Molecular Research in Glioblastoma
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: 31 May 2024 | Viewed by 106
Special Issue Editor
Interests: neuroscience; neuroinflammation; Alzheimer’s disease; ELA
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Glioblastoma, from the neuroglial stem or progenitor cells in brain or spinal cord, can be classified by grade describing their level of abnormality on a scale from I to IV or according to their growth rate, being low, medium and high grade. In this type of tumors, glioblastoma is known to be the most common and aggressive tumor among adults (±90%), being the most malignant possible form of astrocytoma (Grade IV). The main characteristics respect others are the necrosis presence and tumor angiogenesis. On the other hand, anaplastic astrocytoma grade III, less extent than glioblastoma, is characterized by diffuse infiltration inside the neoplasm, nuclear atypia and mitotic activity confirming an anaplasia with an increase in growth rate compared to grade I and II gliomas. In addition, atypical oligodendroglioma (grade II) and anaplastic oligodendroglioma (grade III) exist. Neuroblastoma (from immature nerve cells) is produced from neural crest cells, so tumors can develop anywhere in the sympathetic nervous system. Finally, regarding grade I and II gliomas, both refers to benign tumors diagnosed. Grade I is exclusive detected in childhood and grade II gliomas require follow-up to prevent the tumor from appearing abnormally. This issue is focus in risks, complications and treatment options.
Dr. Soraya L. Valles
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- glioblastoma
- biomarker
- drug treatment
- genetics
